search
Back to results

Novel Home Care Device for High-Risk Diabetic Patients (TempTouchRM)

Primary Purpose

Diabetes, Neuropathic Limb, Elevated Temperature

Status
Unknown status
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
TempTouchRM
Offloading
Sponsored by
Diabetica Solutions Inc.
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Diabetes focused on measuring diabetes, ulceration, amputation, pressure sores, shear friction

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • diagnosis of diabetes by WHO criteria, ability to provide informed consent, 18-80 years of age.

Exclusion Criteria:

  • patients with open ulcers or open amputation sites, active Charcot arthropathy, severe peripheral vascular disease, active foot infection, dementia, impaired cognitive function, history of drug or alcohol abuse within one year of the study, or other conditions based on the PI's clinical judgment.

Sites / Locations

  • Kevin R. Higgins, DPMRecruiting

Outcomes

Primary Outcome Measures

incident foot ulcers

Secondary Outcome Measures

temperature spikes on foot zones

Full Information

First Posted
July 10, 2007
Last Updated
July 11, 2007
Sponsor
Diabetica Solutions Inc.
Collaborators
National Institutes of Health (NIH)
search

1. Study Identification

Unique Protocol Identification Number
NCT00500175
Brief Title
Novel Home Care Device for High-Risk Diabetic Patients
Acronym
TempTouchRM
Official Title
Novel Home Care Device for High-Risk Diabetic Patients
Study Type
Interventional

2. Study Status

Record Verification Date
July 2007
Overall Recruitment Status
Unknown status
Study Start Date
January 2007 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
June 2008 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
Diabetica Solutions Inc.
Collaborators
National Institutes of Health (NIH)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
More than half of all lower extremity amputations are in persons with diabetes. These patients suffer from severe, diabetes-induced, peripheral, sensory neuropathy and, thus they frequently do not protect their feet from repetitive shear stress or traumatic episodes and ulceration often ensues. We have previously shown that the temperature profile of the plantar aspects of the foot provides a reliable warning of tissue injury and can be effectively used as a preventive modality. In this study we propose to further develop and clinically test a novel infrared-based temperature instrument (TempTouchRM®) that is intended for home use by high-risk diabetic patients. This step-on remote monitoring device will serve as an early warning system for impending ulcers and Charcot fractures. The study's central hypothesis is that the TempTouchRM device will reduce the incidence of ulcers by providing an accurate, simple, and effective approach to monitor changes in foot temperatures.
Detailed Description
The study's central hypothesis is that the TempTouchRM device will reduce the incidence of ulcers by providing an accurate, simple, and effective approach to monitor changes in foot temperatures. To study this hypothesis, the following specific aims are proposed: Aim 1: To develop, validate and implement software and protocols for the following: (i) data acquisition and processing, and (ii) the physician-TempTouchRM communications interface. A state-of-the-art web interface will be developed to allow clinicians to view the stored data for their patients. Aim 2: To evaluate the effectiveness of the TempTouchRM in reducing the incidence of diabetic foot ulcers among high-risk patients. Our hypothesis is that patients monitored with the TempTouchRM will have fewer foot ulcers and that the ulcers will be less severe. The 110 patient study will comprise two treatment arms: the standard therapy group and the enhanced therapy group The latter will receive standard care plus infrared temperature monitoring using the TempTouchRM daily for 12 months. Elevated temperatures will provide information to the physician that prevention practices should be initiated, such as off-loading, skin care, etc. Aim 3: To determine the normal range of temperature variations for each individual foot for patients in the Enhanced Therapy and to correlate deviations from this range to the incidence of ulcers. Our previous studies have used the contralateral foot as the control to detect abnormal temperatures. We will investigate the hypothesis that with proper trending of normal foot temperatures, the individual foot can serve as its own control for predicting ulcers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Neuropathic Limb, Elevated Temperature, Shear Pressure, Increased Temperatures
Keywords
diabetes, ulceration, amputation, pressure sores, shear friction

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Single
Allocation
Randomized
Enrollment
110 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
TempTouchRM
Intervention Type
Device
Intervention Name(s)
Offloading
Primary Outcome Measure Information:
Title
incident foot ulcers
Time Frame
one year
Secondary Outcome Measure Information:
Title
temperature spikes on foot zones
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosis of diabetes by WHO criteria, ability to provide informed consent, 18-80 years of age. Exclusion Criteria: patients with open ulcers or open amputation sites, active Charcot arthropathy, severe peripheral vascular disease, active foot infection, dementia, impaired cognitive function, history of drug or alcohol abuse within one year of the study, or other conditions based on the PI's clinical judgment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kevin R HIggins, DPM
Phone
(210) 657-2644
Email
higgins@xilas.com
First Name & Middle Initial & Last Name or Official Title & Degree
Ruben G Zamorano, MSW, MPH
Phone
(210) 692-1114
Ext
119
Email
zamorano@xilas.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kevin R Higgins, DPM
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kevin R. Higgins, DPM
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78217
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ruben G Zamorano, MSW, MPH
Phone
210-692-1114
Ext
119
Email
zamorano@xilas.com

12. IPD Sharing Statement

Learn more about this trial

Novel Home Care Device for High-Risk Diabetic Patients

We'll reach out to this number within 24 hrs